Please click here if you wish to receive an e-mail notification regarding Alector press releases. Year None20242023202220212020201920182017 Jun 20, 2024 Alector to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference Jun 10, 2024 Alector to Host Virtual Research and Development Event Highlighting Alector Brain Carrier Blood-Brain Barrier Technology Platform Jun 03, 2024 Alector to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference May 09, 2024 Alector to Participate in Upcoming Healthcare Conferences May 08, 2024 Alector Reports First Quarter 2024 Financial Results and Provides Business Update Feb 28, 2024 Alector to Participate in Upcoming Healthcare Conferences Feb 27, 2024 Alector Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update Feb 20, 2024 Alector to Host Fourth Quarter and Full-Year 2023 Earnings Call Feb 08, 2024 Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer’s Disease Feb 07, 2024 FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN) Pagination Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 13